Stock BNGO BIONANO GENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
0.968 USD -0.43% Intraday chart for Bionano Genomics, Inc. -9.53% -48.78%
28/05 Bionano Genomics Raises $18 Million From Private Debentures Placement MT
24/05 Bionano Genomics, Inc. announced that it has received $18 million in funding CI

Evolution of the average Target Price on Bionano Genomics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a8a6d6e8f78c80ca92a6c83e3e1c0.PP_jIUoDZmuReeXOAPKPj5J6tg1Jtk-09tMyYAfcCuU.b4-PUTkxISe8EJWkSZjKuvcj1EANhXjyuoBwGmzsJ4NuktVtDFsqHdYS1Q~5490e46428ba355293e11687cef7281a

Analyst Recommendations on Bionano Genomics, Inc.

Scotiabank Trims Price Target on Bionano Genomics to $6 From $7, Maintains Sector Outperform Rating MT
Maxim Group Adjusts Bionano Genomics Price Target to $6 From $30, Maintains Buy Rating MT
EF Hutton Initiates Bionano Genomics at Buy With $1.75 Price Target MT
BTIG Adjusts Price Target on Bionano Genomics to $2 From $3, Maintains Buy Rating MT
Oppenheimer Adjusts Bionano Genomics' Price Target to $9 From $12, Maintains Outperform Rating MT
Scotiabank Initiates Bionano Genomics at Sector Outperform With $4 Price Target MT
BTIG Assumes Bionano Genomics at Buy With $3.50 Price Target MT
Oppenheimer Adjusts Bionano Genomics Price Target to $12 From $14, Maintains Outperform Rating MT
BTIG Adjusts Bionano Genomics' Price Target to $7 From $10, Reiterates Buy Rating MT
Maxim Group Adjusts Bionano Genomics Price Target to $6 From $12, Maintains Buy Rating MT
BIONANO GENOMICS : BTIG Starts Bionano Genomics at Buy With $10 Price Target MT
BIONANO GENOMICS : Oppenheimer Adjusts Bionano Genomics PT to $14 From $15, Maintains Outperform Rating MT
BIONANO GENOMICS : Oppenheimer Adjusts Bionano Genomics' PT to $15 From $1.50, Citing Balance Sheet Expansion, Potential of $100 Genome; Outperform Rating Kept MT
BIONANO GENOMICS : Roth Capital Downgrades Bionano Genomics to Neutral From Buy; Price Target is $0.75 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.968 USD
Average target price
6.667 USD
Spread / Average Target
+588.71%
High Price Target
11 USD
Spread / Highest target
+1,036.36%
Low Price Target
3 USD
Spread / Lowest Target
+209.92%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Bionano Genomics, Inc.

Scotiabank
Maxim
EF Hutton
BTIG
Oppenheimer

Ratings for Bionano Genomics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BNGO Stock
  4. Consensus Bionano Genomics, Inc.